Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China

Ying Wang, Hirokazu Kanegane, Xiaochuan Wang, Xiaohua Han, Qian Zhang, Shunying Zhao, Yeheng Yu, Jingyi Wang, Toshio Miyawaki

Research output: Contribution to journalArticle

18 Citations (Scopus)


Introduction: X-Linked agammaglobulinemia is a prototypical humoral immunodeficiency with the mutation of the Bruton's tyrosine kinase gene. Methods: We investigated the gene mutation and clinical features of 30 Chinese X-linked agammaglobulinemia (XLA) patients from 27 families. There were 26 mutations, including 11 novel and 15 recurrent mutations, distributing over the entire gene. The nucleotide and amino acid aberration, 1129C>T(H333Y) and 1196T>A(I355N), in SH2 have not been reported before. Five (I355N, W124R, R520X, I590F, G594E) of the 24 mutations not detected in the mothers receiving gene analysis were determined to be de novo. Two mutations occurred within intronic splice-site sequences (intron5(-2)A>G, intron17(-2)A>T). Results and Discussion: There are eight mutations in the PH domain, two mutations in the SH3 domain, three mutations in the SH2 domain, one mutation in the TH domain, and other 16 mutations in the TK domain. The mutations of protein domain is most common in TK (53%) domain and then in PH(8%) domain. Missense and nonsense mutations were found equal in 46% of the detected mutations. All of the patients are alive, but one died of liver cancer. Clinical features and serum Igs levels range variedly and were not correlated with genotypes. Our results demonstrated molecular genetic characteristics of XLA in mainland China.

Original languageEnglish
Pages (from-to)352-356
Number of pages5
JournalJournal of Clinical Immunology
Issue number3
Publication statusPublished - May 2009
Externally publishedYes



  • Bruton's tyrosine kinase
  • Humoral immunodeficiency
  • Mutation
  • X-linked agammaglobulinemia

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this